Table 3 The relationship between the Ln-transformed concentration of Klotho protein in research participants and metabolic syndrome along with its components

0.72(0.63,0.83)

< 0.001

0.82(0.70,0.97)

0.018

0.82(0.69,0.96)

0.018

0.82(0.70,0.97)

0.019

0.78(0.67,0.91)

0.002

0.85(0.64,1.14)

0.272

0.83(0.61,1.11)

0.204

0.87(0.64,1.18)

0.365

0.69(0.60,0.80)

< 0.001

0.83(0.71,0.96)

0.016

0.82(0.70,0.97)

0.020

0.83(0.70,0.98)

0.026

0.68(0.60,0.79)

< 0.001

0.75(0.65,0.87)

< 0.001

0.76(0.65,0.89)

< 0.001

0.78(0.67,0.91)

0.003

0.99(0.87,1.12)

0.840

1.00(0.86,1.15)

0.962

1.01(0.88,1.17)

0.855

1.01(0.87,1.17)

0.906

0.88(0.74,1.05)

0.160

1.04(0.87,1.25)

0.635

1.01(0.84,1.22)

0.888

1.02(0.85,1.23)

0.840